In the rapidly evolving world of nanomedicine, “precision drug delivery” is no longer just a vision—it’s becoming reality. And at the heart of this breakthrough lie high-performance nanocarriers.

Enter DMG-pSar25 – a next-gen polymer that’s redefining what’s possible in targeted delivery. Its secret? A smart “anchor + shield” design:

DMG (hydrophobic anchor) – firmly embeds into lipid bilayers, ensuring structural stability.

pSar25 (hydrophilic polysarcosine shell) – forms a robust hydration layer, providing excellent antifouling properties and biocompatibility while evading immune clearance.

This unique structure makes DMG-pSar25 an ideal building block for advanced LNPs and liposomes.

Why Polysarcosine? The PEG Alternative You’ve Been Waiting For

PEG lipids have long been the gold standard for prolonging circulation time—but their limitations are hard to ignore:

Anti-PEG antibodies

Hypersensitivity reactions

Accelerated blood clearance (ABC phenomenon)

Polysarcosine (pSar) – a poly-peptide based on endogenous sarcosine – offers a compelling upgrade:

Biodegradable

Non-toxic

Minimal immunogenicity

Suppresses ABC induction even after repeated dosing

That’s a game-changer for chronic disease treatments like cancer or inflammatory disorders.

Beyond Replacement: Targeted Delivery Potential

By functionalizing the end group of DMG-pSar25, we can covalently attach targeting ligands – enabling precise cell/tissue recognition, reducing off-target effects, and improving therapeutic outcomes.

At Sinopeg, we don’t just supply high-purity polysarcosine – we also offer customization services to accelerate your nanocarrier development.

Emerging Applications

mRNA delivery – protecting nucleic acids from enzymatic degradation

Targeted therapy – reducing chemotherapy side effects

Immunotherapy & regenerative medicine – opening new frontiers

Conclusion

DMG-pSar25 combines structural elegance, low immunogenicity, and targeting potential – making it a powerful candidate for next-gen precision medicine.

Whether you need PEG derivatives or polysarcosine-based solutions, Sinopeg provides integrated, quality-controlled platforms for every R&D need.

Lets shape the future of nanomedicine together.